Skip to main content
Caplight Logo









Last Round

Angel

Feb 10, 2022

Est. Valuation

$225,000

Total Funding Raised

$67,000

Company Overview

London Nootropics is a beverages company that produces adaptogenic coffee blends intended to support focus, energy, and relaxation.

Sector

Consumer & Commerce

Verticals

D2C Brands, E-commerce, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

adaptogenic coffeenootropic coffeemushroom coffeefunctional coffeeadaptogensmedicinal mushroomsDTC brandcoffee subscriptionsubscription commercewellness brandLion's ManeAshwagandha

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

London Nootropics Comparables

Compare London Nootropics with similar companies based on industry and business-model similarity.

London Nootropics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dirtea
88%
Cheerful Buddha
88%
Four Sigmatic
86%

London Nootropics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelFeb 10, 2022

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 10, 2022

    $67K round led by Deborah Meaden and Sara Davies.

London Nootropics Filings

Explore SEC and related filing metadata, where available.

London Nootropics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about London Nootropics's valuation, stock price, and market status.

Is London Nootropics a public or private company?

London Nootropics is a private company.

What is the current stock price of London Nootropics?

London Nootropics is a private company with no public stock price. No recent secondary market data is available.

How much is London Nootropics worth (valuation)?

London Nootropics's valuation is estimated at $225.0K based on funding round data.

Can I buy London Nootropics stock?

London Nootropics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was London Nootropics's last funding round?

London Nootropics's most recent funding round was Angel on February 10, 2022.

Who are the main investors in London Nootropics?

Investor information for London Nootropics is not publicly disclosed.

Will London Nootropics IPO soon?

No public IPO plans have been announced for London Nootropics.

How can I track London Nootropics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor London Nootropics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Year Founded2020
Last FundingFeb 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?